Baystate Wealth Management LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 61 filers reported holding LEAP THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baystate Wealth Management LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5,231
+74628.6%
15,3850.0%0.00%
-100.0%
Q4 2022$7
-100.0%
15,3850.0%0.00%0.0%
Q3 2022$14,000
-22.2%
15,3850.0%0.00%
-50.0%
Q2 2022$18,000
-33.3%
15,3850.0%0.00%0.0%
Q1 2022$27,000
-46.0%
15,3850.0%0.00%
-60.0%
Q4 2021$50,000
-19.4%
15,3850.0%0.01%
-16.7%
Q3 2021$62,00015,3850.01%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 2,664,400$2,345,0002.45%
Key Client Fiduciary Advisors, LLC 1,120,943$986,0000.89%
Knott David M Jr 900,000$792,0000.33%
ACT CAPITAL MANAGEMENT, LLC 265,000$233,0000.32%
Perceptive Advisors 7,472,148$6,575,0000.19%
Tri Locum Partners LP 711,798$626,0000.17%
683 Capital Management, LLC 2,265,000$1,993,0000.15%
Artal Group S.A. 4,000,000$3,520,0000.15%
TANG CAPITAL MANAGEMENT LLC 1,250,000$1,100,0000.14%
HealthCor Management, L.P. 1,066,689$939,0000.12%
View complete list of LEAP THERAPEUTICS INC shareholders